Iranian Journal of Radiology

Published by: Kowsar

Prognostic Value of Diffusion MR Imaging and Clinical-Pathologic Factors in Patients with Rectal Cancer

Yoshifumi Noda 1 , Satoshi Goshima 1 , * , Kimihiro Kajita 2 , Hiroshi Kawada 1 , Nobuyuki Kawai 1 , Hiromi Koyasu 1 , Masayuki Matsuo 1 and Kyongtae T Bae 3
Authors Information
1 Departments of Radiology, Gifu University, Gifu, Japan
2 Departments of Radiology Services, Gifu University, Gifu, Japan
3 Department of Radiology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA
Article information
  • Iranian Journal of Radiology: January 2018, 15 (1); e57080
  • Published Online: January 29, 2018
  • Article Type: Research Article
  • Received: January 10, 2017
  • Revised: June 26, 2017
  • Accepted: October 9, 2017
  • DOI: 10.5812/iranjradiol.57080

To Cite: Noda Y, Goshima S, Kajita K, Kawada H, Kawai N, et al. Prognostic Value of Diffusion MR Imaging and Clinical-Pathologic Factors in Patients with Rectal Cancer, Iran J Radiol. 2018 ; 15(1):e57080. doi: 10.5812/iranjradiol.57080.

Copyright © 2018, Iranian Journal of Radiology. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65(1):5-29. doi: 10.3322/caac.21254. [PubMed: 25559415].
  • 2. Lee YC, Hsieh CC, Chuang JP. Prognostic significance of partial tumor regression after preoperative chemoradiotherapy for rectal cancer: a meta-analysis. Dis Colon Rectum. 2013;56(9):1093-101. doi: 10.1097/DCR.0b013e318298e36b. [PubMed: 23929020].
  • 3. Tarantino I, Warschkow R, Worni M, Merati-Kashani K, Koberle D, Schmied BM, et al. Elevated preoperative CEA is associated with worse survival in stage I-III rectal cancer patients. Br J Cancer. 2012;107(2):266-74. doi: 10.1038/bjc.2012.267. [PubMed: 22735902].
  • 4. Boras Z, Kondza G, Sisljagic V, Busic Z, Gmajnic R, Istvanic T. Prognostic factors of local recurrence and survival after curative rectal cancer surgery: a single institution experience. Coll Antropol. 2012;36(4):1355-61. [PubMed: 23390833].
  • 5. Minsky BD, Mies C, Rich TA, Recht A. Lymphatic vessel invasion is an independent prognostic factor for survival in colorectal cancer. Int J Radiat Oncol Biol Phys. 1989;17(2):311-8. doi: 10.1016/0360-3016(89)90445-8. [PubMed: 2546907].
  • 6. Colorectal Cancer Collaborative G. Adjuvant radiotherapy for rectal cancer: a systematic overview of 8,507 patients from 22 randomised trials. Lancet. 2001;358(9290):1291-304. doi: 10.1016/S0140-6736(01)06409-1. [PubMed: 11684209].
  • 7. Bellows CF, Jaffe B, Bacigalupo L, Pucciarelli S, Gagliardi G. Clinical significance of magnetic resonance imaging findings in rectal cancer. World J Radiol. 2011;3(4):92-104. doi: 10.4329/wjr.v3.i4.92. [PubMed: 21532870].
  • 8. Curvo-Semedo L, Lambregts DM, Maas M, Beets GL, Caseiro-Alves F, Beets-Tan RG. Diffusion-weighted MRI in rectal cancer: apparent diffusion coefficient as a potential noninvasive marker of tumor aggressiveness. J Magn Reson Imaging. 2012;35(6):1365-71. doi: 10.1002/jmri.23589. [PubMed: 22271382].
  • 9. Akashi M, Nakahusa Y, Yakabe T, Egashira Y, Koga Y, Sumi K, et al. Assessment of aggressiveness of rectal cancer using 3-T MRI: correlation between the apparent diffusion coefficient as a potential imaging biomarker and histologic prognostic factors. Acta Radiol. 2014;55(5):524-31. doi: 10.1177/0284185113503154. [PubMed: 24005562].
  • 10. Tong T, Yao Z, Xu L, Cai S, Bi R, Xin C, et al. Extramural depth of tumor invasion at thin-section MR in rectal cancer: associating with prognostic factors and ADC value. J Magn Reson Imaging. 2014;40(3):738-44. doi: 10.1002/jmri.24398. [PubMed: 24307597].
  • 11. Smith NJ, Shihab O, Arnaout A, Swift RI, Brown G. MRI for detection of extramural vascular invasion in rectal cancer. AJR Am J Roentgenol. 2008;191(5):1517-22. doi: 10.2214/AJR.08.1298. [PubMed: 18941094].
  • 12. Sun Y, Tong T, Cai S, Bi R, Xin C, Gu Y. Apparent Diffusion Coefficient (ADC) value: a potential imaging biomarker that reflects the biological features of rectal cancer. PLoS One. 2014;9(10). e109371. doi: 10.1371/journal.pone.0109371. [PubMed: 25303288].
  • 13. NIH. NIH consensus conference. Adjuvant therapy for patients with colon and rectal cancer. JAMA. 1990;264(11):1444-50. doi: 10.1001/jama.1990.03450110090034. [PubMed: 2202842].
  • 14. Valentini V, Aristei C, Glimelius B, Minsky BD, Beets-Tan R, Borras JM, et al. Multidisciplinary Rectal Cancer Management: 2nd European Rectal Cancer Consensus Conference (EURECA-CC2). Radiother Oncol. 2009;92(2):148-63. doi: 10.1016/j.radonc.2009.06.027. [PubMed: 19595467].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments